Hidden Consequences of Interim Analyses & Adaptive Trial Options

Por um escritor misterioso

Descrição

Hidden Consequences of Interim Analyses & Adaptive Trial Options
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Hidden Consequences of Interim Analyses & Adaptive Trial Options
An overview of platform trials with a checklist for clinical readers - ScienceDirect
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Roche inadvertently publishes positive interim trial data on lung cancer drug
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Adaptive Design Clinical Trials
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency, Trials
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Adaptive Designs for Clinical Trials
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Randomized Trials in Cardiac Surgery: JACC Review Topic of the Week
Hidden Consequences of Interim Analyses & Adaptive Trial Options
Frontiers Assessing the efficacy of immunotherapy in lung squamous carcinoma using artificial intelligence neural network
de por adulto (o preço varia de acordo com o tamanho do grupo)